EMEA-000568-PIP01-09-M06
Key facts
Invented name |
Cinryze
|
Active substance |
C1 inhibitor (human)
|
Therapeutic area |
Immunology-Rheumatology-Transplantation
|
Decision number |
P/0299/2015
|
PIP number |
EMEA-000568-PIP01-09-M06
|
Pharmaceutical form(s) |
Powder and solvent for solution for injection
|
Condition(s) / indication(s) |
Treatment of C1 inhibitor deficiency
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
NPS Pharma Holdings Limited
|
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-000568-PIP01-09-M06
|
Compliance opinion date |
26/02/2016
|
Compliance outcome |
positive
|